| Literature DB >> 27314319 |
Xiao-Jun Li1,2, Wan-Rong Bao3, Chung-Hang Leung4, Dik-Lung Ma5, Ge Zhang6, Ai-Ping Lu7, Shun-Chun Wang8, Quan-Bin Han9.
Abstract
A neutral α-glucan, named BP1, with a molecular mass of approximately 9.45 kDa, was isolated from Lobelia chinensis by hot-water extraction, a Q-Sepharose Fast Flow column and Superdex-75 column chromatography. Its chemical structure was characterized by monosaccharide analysis, methylation analysis and analysis of its FT-IR, high performance gel permeation chromatography (HPGPC) and 1D/2D-NMR spectra data. The backbone of BP1 consists of →₆α-d-Glcp¹→6,3α-d-Glcp¹→(₆α-d-Glcp¹)x-6,3α-d-Glcp¹-(₆α-d-Glcp¹)y→. The side chains were terminal α-d-Glcp¹→ and α-d-Glcp¹→ (₆α-d-Glcp¹)z→₄α-d-Glcp¹→₃α-d-Glcp¹→₄α-d-Glcp¹→ (x + y + z = 5), which are attached to the backbone at O-3 of 3,6α-d-Glcp¹. The results of the effect of BP1 on mouse macrophage cell line RAW 264.7 indicate that BP1 enhances the cell proliferation, phagocytosis, nitric oxide production and cytokine secretion in a dose-dependent manner. Because the inhibitor of Toll-like receptor 4 blocks the BP1-induced secretion of TNF-α and IL-6, we hypothesize that α-glucan BP1 activates TLR4, which mediates the above-mentioned immunomodulating effects.Entities:
Keywords: Lobelia chinensis; NMR; RAW 264.7; TLR4; immunomodulating
Mesh:
Substances:
Year: 2016 PMID: 27314319 PMCID: PMC6274272 DOI: 10.3390/molecules21060779
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) The Q-Sepharose column chromatography of crude polysaccharide extracted from Lobelia chinensis; (B) gel filtration chromatography of the major fraction (0.2 NaCl elution) on Superdex 75; (C) homogeneity of BP1 as measured by high performance gel permeation chromatography (HPGPC); (D) monosaccharide composition of BP1 (upper: reference standards; lower: BP1).
Linkages and individual molar ratios of BP1 elucidated by methylation analysis.
| Methylation Sugars | Linkages | Retention Time (min) | Molar Ratio | Main Mass Fragment ( |
|---|---|---|---|---|
| 2,3,4,6-Me4-Glcp | Glc-1 | 28.358 | 2.01 | 43 (100), 71 (20), 87 (25), 101 (65), 117 (50), 129 (48), 145 (40), 161 (45), 205 (10) |
| 2,3,4-Me3-Glcp | Glc-1,6 | 36.061 | 5.97 | 43 (100), 71 (15), 87 (33), 99 (40), 101 (52), 117 (55), 129 (37), 161 (15), 173 (5), 189 (10), 233 (10) |
| 2,3,6-Me3-Glcp | Glc-1,4 | 34.539 | 2.03 | 43 (100), 71 (5), 87 (18), 99 (15), 101 (20), 113 (15), 117 (45), 129 (5), 161 (3), 233 (20) |
| 2,4,6-Me3-Glcp | Glc-1,3 | 33.862 | 0.99 | 43 (100), 71 (16), 87 (25), 99 (15), 101 (38), 113 (5), 117 (85), 129 (70), 161 (30), 173 (5), 233 (10) |
| 2,4-Me2-Glcp | Glc-1,3,6 | 42.231 | 2.01 | 43 (100), 71 (5), 87 (25), 99 (10), 101 (5), 117 (32), 129 (45), 189 (15), 233 (5) |
* The symbol m stands for mass and z stands for the charge number of ions. m/z represents mass divided by charge number.
Signal assignments of the 1H- and 13C-NMR spectra of BP1 based on the analysis of H-HCOSY, HSQC and HMBC spectra [21,22,23,24].
| Glycosyl Residues | C1 | C2 | C3 | C4 | C5 | C6 | |
|---|---|---|---|---|---|---|---|
| H1 | H2 | H3 | H4 | H5 | H6a | H6b | |
| A: 6α- | 99.0 | 73.1 | 74.3 | 70.8 | 71.4 | 66.8 | |
| 4.85~4.90 | 3.44~3.48 | 3.60~3.64 | 3.40~3.43 | 3.80~3.83 | 3.64~3.66 | 3.86~3.90 | |
| B: 3,6α- | 98.9 | 72.4 | 81.7 | 74.1 | 70.6 | 66.6 | |
| 4.88~4.91 | 3.54~3.59 | 3.73~3.77 | 3.89~3.93 | 3.33~3.37 | 3.58~3.67 | 3.86~3.90 | |
| C: 4α- | 101.0 | 71.4 | 74.6 | 78.0 | 71.6 | 61.8 | |
| 5.29~5.32 | 3.52~3.54 | 3.84~3.88 | 3.55~3.58 | 3.73~3.77 | 3.67~3.69 | 3.73~3.75 | |
| D: 3α- | 100.8 | 72.4 | 82.3 | 71.4 | 74.3 | 61.8 | |
| 5.28~5.30 | 3.49~3.50 | 3.73~3.77 | 3.36~3.38 | 3.62~3.66 | 3.67~3.69 | 3.73~3.75 | |
| E: α- | 100.6 | 72.7 | 71.4 | 73.9 | 71.5 | 61.6 | |
| 5.22~5.26 | 3.44~3.48 | 4.09~4.12 | 3.89~3.92 | 3.34~3.38 | 3.67~3.69 | 3.73~3.75 | |
Figure 21D-NMR spectra of BP1. (A) 1H-NMR; (B) 13C-NMR; (C) DEPT135-NMR and (D) 13C-NMR of BP1a. The signals highlighted in red indicate the changes of C1, C3 of 3α-d-Glcp1 and C4 of 4α-d-Glcp1 caused by partial acid hydrolysis.
Figure 3HMBC spectra of BP1: The inter-residue 1H-13C long-range correlations used for linkage and sequence assignments are listed in Table 3.
The significant 3JH,C correlations observed in the HMBC spectrum of BP1.
| No. | Glycosyl Residues | Atom | Residue | δC | Atom | Residue | δH |
|---|---|---|---|---|---|---|---|
| A | 6α- | AH1 | AC3 a | 74.6 | AC1 | AH2 | 3.44~3.48 |
| 4.88 | AH1 | AC5 a | 71.4 | AC1 | AH6a | 3.64~3.66 | |
| AH1 | AC6 | 66.8 | AC1 | BH6a b | 3.56~3.61 | ||
| AH1 | BC3 | 81.7 | AC1 | CC3 | 3.84~3.88 | ||
| AH1 | BC6 b | 66.6 | |||||
| AH1 | CC2 | 71.4 | |||||
| AH1 | CC3 | 74.6 | |||||
| B | 3,6α- | BH1 | AC2 | 73.1 | BC1 | AH6a c | 3.64~3.66 |
| 4.87 | BH1 | AC4 | 70.8 | BC1 | BH6a | 3.56~3.61 | |
| BH1 | AC6 c | 66.8 | |||||
| BH1 | BC3 a | 81.7 | |||||
| BH1 | BC5 a | 70.6 | |||||
| BH1 | BC6 | 66.6 | |||||
| C | 4α- | CH1 | BC2 | 72.4 | CC1 | DH3 d | 3.73~3.77 |
| 5.31 | CH1 | BC3 e | 74.6 | CC1 | BH3 e | 3.73~3.77 | |
| CH1 | DC2 | 72.4 | CC1 | CH4 | 3.57~3.58 | ||
| CH1 | CC4 | 78.0 | |||||
| D | 3α- | DH1 | BC2 | 72.4 | DC1 | CH4 f | 3.57~3.58 |
| 5.29 | DH1 | CC3 | 74.6 | ||||
| DH1 | DC2 | 72.4 | |||||
| DH1 | CC4 f | 78.0 | |||||
| E | α- | EH1 | BC4 | 74.1 | EC1 | BH3 g | 3.73~3.77 |
a For the presence of α-configurations; b For →6α-d-Glcp1→6,3α-d-Glcp1→; c For →6,3α-d-Glcp1→6α-d-Glcp1; d For →4α-d-Glcp1→3α-d-Glcp1→; e For →4α-d-Glcp1→3,6α-d-Glcp1→; f For →3α-d-Glcp1→4α-d-Glcp1→; g For α-d-Glcp1→3,6α-d-Glcp1→.
Figure 4NOESY spectrum of BP1. NOE correlations are labelled with residue and proton/carbon numbers, as listed in Table 4.
Assignment of the NOESY spectra of BP1.
| Anomeric Proton | NOE Contact Proton | δH | Glycosyl Residue |
|---|---|---|---|
| AH1 | AH2 | 3.44~3.48 | |
| AH5 | 3.80~3.83 | ||
| AH6a | 3.64~3.66 | ||
| AH6b | 3.88~3.90 | ||
| BH6a | 3.59~3.61 | →6α- | |
| BH6b | 3.88~3.90 | →6α- | |
| CH4 | 3.57~3.58 | →6α- | |
| BH1 | BH2 | 3.54~3.59 | |
| BH3 | 3.73~3.77 | ||
| CH1 | CH2 | 3.52~3.54 | |
| CH3 | 3.73~3.77 | ||
| BH3 | 3.73~3.77 | ||
| DH1 | CH4 | 3.57~3.58 | →3α- |
| DH1 | CH3 | 3.84~3.88 | |
| EH1 | BH3 | 3.73~3.77 | α- |
| AH2 | 3.44~3.48 | ||
| AH3 | 3.60~3.64 | ||
| AH6a | 3.64~3.66 | α- | |
| AH6b | 3.88~3.90 | α- |
Figure 52D-NMR spectrum of BP1. (A) 1H-1H COSY spectra of BP1; (B) HSQC spectra of BP1. The cross-peaks are labelled with the residue and number; residue names are the same as those in Table 2.
Figure 6The proposed chemical structure of BP1. (A) 6α-d-Glcp1; (B) 3,6α-d-Glcp1; (C) 4α-d-Glcp1; (D) 3α-d-Glcp1; (E) α-d-Glcp1. The symbols of x, y and z were used to express the number of 6α-d-Glcp1.
Figure 7Immunomodulating effects of BP1. (A) Dose-dependent induction of the proliferation of RAW 264.7 cells; (B) dose-dependent effect on the production of NO by RAW 264.7 cells in vitro; (C) induction of RAW 264.7 cell TNF-α secretion in vitro, and the role of TLR4 in this bioactivity; (D) Induction of RAW 264.7 cell IL-6 secretion in vitro, and the role of TLR4 in this bioactivity. LPS (2 µg/mL) and LPS + polymyxin B (PolyB) served as the positive control and endotoxin-excluded control, respectively. Each value is expressed as the mean ± SD (n = 3). Level of significance: ** p < 0.01; *** p < 0.001 compared to untreated cells (at 0 µg/mL).
Figure 8Inducing the effect of BP1 on the phagocytosis to FITC-labeled dextran (12 kDa) by RAW 264.7 cells in a dose-dependent manner. LPS (2 µg/mL) and LPS + polymyxin B served as the positive control and endotoxin-excluded control, respectively. Each value is expressed as the mean ± SD (n = 3). Level of significance: * p < 0.05, ** p < 0.01 compared to untreated cells (at 0 µg/mL).